Sequence Bio is a biotechnology company based in St. John's, Newfoundland and Labrador. Situated on the east coast of Canada, we are a dedicated team of local and global specialists utilizing our province's founder effect to uncover the authentic signals of illness in order to drive transformative medications. Through the amalgamation of founder population multi-omics, real-world patient data, and well-defined phenotypes, we are adopting a systems biology approach to expedite the discovery of more effective drug targets.